Intracoronary tenecteplase versus abciximab as adjunctive treatment during primary percutaneous coronary intervention in patients with anterior myocardial infarction-Reference-Cited by-同舟云学术

Intracoronary tenecteplase versus abciximab as adjunctive treatment during primary percutaneous coronary intervention in patients with anterior myocardial infarction

Published:2019-03 Issue:16 Volume:14 Page:1668-1675
ISSN:1774-024X
Container-title:EuroIntervention
language:
Short-container-title:EuroIntervention

Author:

Morales-Ponce Francisco J.,Lozano-Cid Francisco J.,Martinez-Romero Pedro,Gonzalez-Perez Pablo,Sanchez-Brotons Juan A.,Diaz-Torres Isabel,Rodriguez-Yanez Juan C.,Caro-Mateo Pilar,Serrador-Frutos Ana M.

Publisher

Europa Digital & Publishing

Subject

Cardiology and Cardiovascular Medicine

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intracoronary antithrombotic therapy during primary percutaneous coronary intervention in patients with STEMI: A systematic review and network meta-analysis;Thrombosis Research;2024-01

2. Preventive use of glycoprotein IIb/IIIa inhibitors in patients with ST-segment elevation myocardial infarction and a high risk of no-reflow phenomenon;The Siberian Journal of Clinical and Experimental Medicine;2023-07-06

3. Safety and efficacy of intracoronary thrombolytic agents during primary percutaneous coronary intervention for STEMI;Expert Review of Cardiovascular Therapy;2023-03-03

4. Intracoronary pharmacological therapy versus aspiration thrombectomy in STEMI (IPAT-STEMI): A systematic review and meta-analysis of randomized trials;PLOS ONE;2022-05-05

5. Acute Coronary Syndromes (ACS)—Unravelling Biology to Identify New Therapies—The Microcirculation as a Frontier for New Therapies in ACS;Cells;2021-08-25